Skip Navigation

Nucleic Acids Research 2005 33(1):27-42; doi:10.1093/nar/gki142
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (7890K) Freely available
Right arrow Screen PDF (973K) Freely available
Right arrow Supplementary Material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (49)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Turner, J. J.
Right arrow Articles by Gait, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turner, J. J.
Right arrow Articles by Gait, M. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published online 7 January 2005

© 2005, the authors Nucleic Acids Research, Vol. 33 No. 1 © Oxford University Press 2005; all rights reserved
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use permissions, please contact journals.permissions{at}oupjournals.org.

Article

Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides

John J. Turner, Andrey A. Arzumanov and Michael J. Gait*

Medical Research Council, Laboratory of Molecular Biology Hills Road, Cambridge CB2 2QH, UK

*To whom correspondence should be addressed. Tel: +44 1223 248011; Fax: +44 1223 402070; Email: mgait{at}mrc-lmb.cam.ac.uk

Received November 4, 2004. Revised December 1, 2004. Accepted December 1, 2004.

Oligonucleotides composed of 2'-O-methyl and locked nucleic acid residues complementary to HIV-1 trans-activation responsive element TAR block Tat-dependent trans-activation in a HeLa cell assay when delivered by cationic lipids. We describe an improved procedure for synthesis and purification under highly denaturing conditions of 5'-disulphide-linked conjugates of 3'-fluorescein labelled oligonucleotides with a range of cell-penetrating peptides and investigate their abilities to enter HeLa cells and block trans-activation. Free uptake of 12mer OMe/LNA oligonucleotide conjugates to Tat (48–58), Penetratin and R9F2 was observed in cytosolic compartments of HeLa cells. Uptake of the Tat conjugate was enhanced by N-terminal addition of four Lys or Arg residues or a second Tat peptide. None of the conjugates entered the nucleus or inhibited trans-activation when freely delivered, but inhibition was obtained in the presence of cationic lipids. Nuclear exclusion was seen for free delivery of Tat (48–58), Penetratin and R9 conjugates of 16mer phosphorothioate OMe oligonucleotide. Uptake into human fibroblast cytosolic compartments was seen for Tat, Penetratin, R9F2 and Transportan conjugates. Large enhancements of HeLa cell uptake into cytosolic compartments were seen when free Tat peptide was added to Tat conjugate of 12mer OMe/LNA oligonucleotide or Penetratin peptide to Penetratin conjugate of the same oligonucleotide.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
G. D. Ivanova, A. Arzumanov, R. Abes, H. Yin, M. J. A. Wood, B. Lebleu, and M. J. Gait
Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle
Nucleic Acids Res., November 1, 2008; 36(20): 6418 - 6428.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
R. Juliano, Md. R. Alam, V. Dixit, and H. Kang
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
Nucleic Acids Res., July 1, 2008; 36(12): 4158 - 4171.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. J. Tacken, B. Joosten, A. Reddy, D. Wu, A. Eek, P. Laverman, A. Kretz-Rommel, G. J. Adema, R. Torensma, and C. G. Figdor
No Advantage of Cell-Penetrating Peptides over Receptor-Specific Antibodies in Targeting Antigen to Human Dendritic Cells for Cross-Presentation
J. Immunol., June 1, 2008; 180(11): 7687 - 7696.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
M. R. Alam, V. Dixit, H. Kang, Z.-B. Li, X. Chen, J. Trejo, M. Fisher, and R. L. Juliano
Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis
Nucleic Acids Res., May 1, 2008; 36(8): 2764 - 2776.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
C. Dow-Tien, T. Yuan-Jhih, and L. Alan
Creating a ribonuclease T-tat that preferentially recognizes and hydrolyzes HIV-1 TAR RNA in vitro and in vivo
Nucleic Acids Res., February 11, 2008; 36(3): 963 - 969.
[Abstract] [Full Text] [PDF]

Home page
 RNAHome page
M. M. Fabani and M. J. Gait
miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates
RNA, February 1, 2008; 14(2): 336 - 346.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
K. Gogoi, M. V. Mane, S. S. Kunte, and V. A. Kumar
A versatile method for the preparation of conjugates of peptides with DNA/PNA/analog by employing chemo-selective click reaction in water
Nucleic Acids Res., December 18, 2007; 35(21): e139 - e139.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
P. Lundberg, S. El-Andaloussi, T. Sutlu, H. Johansson, and U. Langel
Delivery of short interfering RNA using endosomolytic cell-penetrating peptides
FASEB J, September 1, 2007; 21(11): 2664 - 2671.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
S. Abes, J. J. Turner, G. D. Ivanova, D. Owen, D. Williams, A. Arzumanov, P. Clair, M. J. Gait, and B. Lebleu
Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide
Nucleic Acids Res., July 26, 2007; 35(13): 4495 - 4502.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
S. Veldhoen, S. D. Laufer, A. Trampe, and T. Restle
Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect
Nucleic Acids Res., December 2, 2006; 34(22): 6561 - 6573.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
V. Marchan, S. Ortega, D. Pulido, E. Pedroso, and A. Grandas
Diels-Alder cycloadditions in water for the straightforward preparation of peptide-oligonucleotide conjugates
Nucleic Acids Res., February 14, 2006; 34(3): e24 - e24.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
J. J. Turner, G. D. Ivanova, B. Verbeure, D. Williams, A. A. Arzumanov, S. Abes, B. Lebleu, and M. J. Gait
Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells
Nucleic Acids Res., November 30, 2005; 33(21): 6837 - 6849.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.